Maybe someone finally read the 10Q and saw this--
Looking forward into the second quarter of 2015, given our projection of inventory that should be available to sell, we expect to see a decrease in sales of approximately 15% to 20% in comparison to the second quarter of 2014, as we work to re-build our inventory levels.
100% agree. And I love this move by our recently appointed CEO. Voluntarily reducing his salary to $1 until the company starts making money again. If only more CEOs would do this! Palle really seems determined to turn this thing around. A welcome change from our prior CEO.
From the 8K today:
As previously disclosed, Mr. Pallé had voluntarily reduced his compensation from $328,015 to $131,206 effective as of February 23, 2015. Mr. Pallé subsequently agreed to reduce his salary compensation to $1.00 effective as of April 13, 2015, also on a voluntary basis until sometime in the fourth quarter of 2015, or at some earlier date after which the Company’s liquidity was adequately improved.
Glad to hear it. Market keeps going up every day and MNDO one of the cheapest stocks out there. Trailing P/E below 9, great balance sheet with a ton of cash, plus a huge 10% dividend yield.
I would turn your money over to professionals or just buy index funds. If you're shorting one of the cheapest stocks on Nasdaq, you're asking to lose money. Stock was undervalued at $3. At $2.40, it's a screaming buy. There's 10% downside, 50-100% upside. The risk/reward is VERY favorable on the long side. Can understand it may not be everyone's cup of tea. But to go short at these low levels is insane!
Maybe it will be down. I guess that's where you're hoping to buy (as per your post above). Nobody knows what will happen tomorrow. Not me, not you. All I know is MNDO is deeply oversold, is very profitable, has a rock solid balance sheet, and pays out a juicy dividend. Buyers will return at some point. Maybe tomorrow, maybe next month. The downside is 10% while the upside potential is 50% or more. So I'd say the risk/reward profile greatly favors the longs at this depressed price.
Oh I just looked thru some of your posts on this board. Looks like you covered your short way too early and are now looking to go long. Guess that explains why you're trying to talk it down. Jeez just buy in the $2.30's and take the gift.
redbear358 • May 4, 2015 9:35 AM
For what it's worth...
I liquidated my short position at $3.22 a share and bought BLRX another Israeli company at $1.75 a share. No dividend, but lots of upside potential as its trials are coming to a close. Today, it was up $.10 cents. Obvioussly the share price will fluctuate, but the upside looks very promising.
redbear358 • May 6, 2015 8:08 PM
Tomorrow will be a better day.
I anticipate that MNDO will open up tomorrow at $2.52 and trade down to $2.48 before settling at the close tomorrow at $2.44. I know that this is creating a great buying opportunity, as I have my orders in at $2.21 a share. Stay tuned for more.
Do you know how to read an earnings statement? Or a balance sheet? Maybe that explains why you're short a stock with excellent fundamental strength, and long a risky biotech with zero revenue and huge losses.
My 20+ years of investing in smallcaps & microcaps says that isn't true. There have been plenty of stocks in the $1-$2 range that have been huge winners for me over the years. Sometimes you have to buy stocks when nobody wants em, then sell when everybody does. Use other people's impatience to your advantage.
As for MNDO, it's too cheap here. Yeah I know last quarter wasn't great and the next quarter or 2 prob won't be too hot either. But eventually we'll see revenues rebound. And earnings back up near .10/share per quarter. Maybe it takes a year. Maybe not that long. What I do know is when that happens, those who bought in the $2.30's will be sitting on a BIG gain.
Well panic selling in the sense that the stock had already been beat up. From $4+ to the $2.5-$2.75 range. Last quarter wasn't great, but certainly not the end of the world. This company is still posting nice profits, has an excellent balance sheet, and pays out a huge dividend. So the selling in the $2.30's sure doesn't make any sense to me. If anyone knows of a cheaper Nasdaq stock, by all means, please post it!
Good call if you did actually short. But if you did, you would surely be covering today. With earnings of .05/share last quarter, a balance sheet with .80/share in cash & investments, and a 10% annual dividend yield...the stock is a bargain. Find me a cheaper one anywhere on Nasdaq. Why be short one of the cheapest stocks in the entire market...when there's thousands of overvalued stocks out there?
Yeah what the heck happened today? Could have sold at $3 after earnings. Who would wait til the $2.30's? Seems like panic selling. Maybe an opportunity. Stock is worth buying for the dividend alone!
I wish they would cut expenses! Get back to the consistent profitability they enjoyed a few years ago before this foray into commercial products. Hasn't worked out so far. They probably should just sell the company.
Surprised to see stock down so much when it was already close to its lows. Were people expecting the outlook to be that great??
Great catch! Looks like something good is brewing at BSQR. We should find out more when they report Q1 results in 2 weeks. Surprised to see the stock back down in the $4.20's, but gladly buying more. We know Q1 is seasonally weak, but they should still be able to manage a small profit vs. the loss last year. Then we have the stronger quarters coming up and I think the outlook will be quite bullish. Excellent balance sheet with $2.20/share in cash & investments. This stock would be undervalued at $5-$6 imo.
Yeah Q1 nothing to write home about. But the company is still nicely profitable, is sitting on a terrific balance sheet with tons of cash, and pays out a huge annual dividend. The 10% dividend alone is reason enough to own this stock! Will gladly keep buying as people throw away their shares in the $2.60's.
Yeah we knew they were gonna miss the revenue estimates given other news from the sector. The slight drop from $133M-$138M down to $124M-$130M doesn't seem that bad at all! Plus they'll now pay an even lower price for Nexgen, and keep even more cash on the balance sheet. I'll be buying on today's selloff. PCTI seems like a bargain below $7.